554 related articles for article (PubMed ID: 12067140)
21. Folinic acid, 5-fluorouracil and mitomycin C in metastatic breast cancer patients previously treated with at least two chemotherapy regimens.
Francini G; Petrioli R; Messinese S; Pozzessere D; Marsili S; Correale P; Sabatino M; Fiaschi AI
Cancer Chemother Pharmacol; 2002 Oct; 50(4):271-6. PubMed ID: 12357300
[TBL] [Abstract][Full Text] [Related]
22. Phase II study of vinorelbine with protracted fluorouracil infusion as a second- or third-line approach for advanced breast cancer patients previously treated with anthracyclines.
Berruti A; Sperone P; Bottini A; Gorzegno G; Lorusso V; Brunelli A; Botta M; Tampellini M; Donadio M; Mancarella S; De Lena M; Alquati P; Dogliotti L
J Clin Oncol; 2000 Oct; 18(19):3370-7. PubMed ID: 11013277
[TBL] [Abstract][Full Text] [Related]
23. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
[TBL] [Abstract][Full Text] [Related]
24. Late phase II clinical study of vinorelbine monotherapy in advanced or recurrent breast cancer previously treated with anthracyclines and taxanes.
Toi M; Saeki T; Aogi K; Sano M; Hatake K; Asaga T; Tokuda Y; Mitsuyama S; Kimura M; Kobayashi T; Tamura M; Tabei T; Shin E; Nishimura R; Ohno S; Takashima S
Jpn J Clin Oncol; 2005 Jun; 35(6):310-5. PubMed ID: 15930037
[TBL] [Abstract][Full Text] [Related]
25. Continuous infusion 5-fluorouracil as first-line therapy for metastatic breast cancer.
Chu L; Sutton LM; Peterson BL; Havlin KA; Winer EP
J Infus Chemother; 1996; 6(4):211-6. PubMed ID: 9229318
[TBL] [Abstract][Full Text] [Related]
26. Phase I studies of fluorouracil, doxorubicin and vinorelbine without (FAN) and with (SUPERFAN) folinic acid in patients with advanced breast cancer.
Goss PE; Fine S; Gelmon K; Rudinskas L; Ottaway J; Myles J; James K; Paul K; Rodgers A; Pritchard KI
Cancer Chemother Pharmacol; 1997; 41(1):53-60. PubMed ID: 9443614
[TBL] [Abstract][Full Text] [Related]
27. Phase II study of epirubicin plus oxaliplatin and infusional 5-fluorouracil as first-line combination therapy in patients with metastatic or advanced gastric cancer.
Zhang CX; Huang S; Xu N; Fang JW; Shen P; Bao YH; Mou BH; Shi MG; Zhong XL; Xiong PJ
Anticancer Drugs; 2007 Jun; 18(5):581-6. PubMed ID: 17414627
[TBL] [Abstract][Full Text] [Related]
28. Oral vinorelbine/paclitaxel combination treatment of metastatic breast cancer: a phase I study.
Delva R; Pienkowski T; Tubiana N; Vanhoefer U; Longerey B; Douville I
Cancer Chemother Pharmacol; 2007 May; 59(6):703-9. PubMed ID: 17021821
[TBL] [Abstract][Full Text] [Related]
29. Combination of vinorelbine + doxorubicin in advanced breast cancer.
Lorvidhaya V; Kamnerdsupaphon P; Chitapanarux I; Srisukho S; Trakultivakorn H; Sumitsawan S; Sukthomya V; Tonusin A
Gan To Kagaku Ryoho; 2003 Aug; 30(8):1131-8. PubMed ID: 12938268
[TBL] [Abstract][Full Text] [Related]
30. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).
Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR
Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207
[TBL] [Abstract][Full Text] [Related]
31. The raltitrexed-vinorelbine combination: a phase I pharmacokinetic and pharmacodynamic trial in advanced breast cancer.
Ferrero JM; Chamorey E; Magné N; Leccia F; Largillier R; Namer M; Milano G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):459-64. PubMed ID: 12451472
[TBL] [Abstract][Full Text] [Related]
32. UFT plus oral folinic acid with alternating oral and intravenous vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes.
Coşkun U; Kaya AO; Alkis N; Buyukberber S; Alici S; Celenkoglu G; Uncu D; Ozkan M; Sevinc A; Benekli M
Onkologie; 2009 Oct; 32(10):562-6. PubMed ID: 19816072
[TBL] [Abstract][Full Text] [Related]
33. A phase II study of lipoplatin (liposomal cisplatin)/vinorelbine combination in HER-2/neu-negative metastatic breast cancer.
Farhat FS; Temraz S; Kattan J; Ibrahim K; Bitar N; Haddad N; Jalloul R; Hatoum HA; Nsouli G; Shamseddine AI
Clin Breast Cancer; 2011 Dec; 11(6):384-9. PubMed ID: 21993011
[TBL] [Abstract][Full Text] [Related]
34. A prospective, randomized Phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinoma.
Blajman C; Balbiani L; Block J; Coppola F; Chacon R; Fein L; Bonicatto S; Alvarez A; Schmilovich A; Delgado FM
Cancer; 1999 Mar; 85(5):1091-7. PubMed ID: 10091793
[TBL] [Abstract][Full Text] [Related]
35. Vinorelbine and infusional 5-fluorouracil in anthracycline and taxane pre-treated metastatic breast cancer.
Stuart NS; McIllmurray MB; Bishop JL; Johnston SR; Price CG; O'Reilly SM; Joffe JK; Neave F; Whipp EC
Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):152-6. PubMed ID: 18083354
[TBL] [Abstract][Full Text] [Related]
36. A phase I study of vinflunine in combination with capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes.
Campone M; Isambert N; Bourbouloux E; Roché H; Bonneterre J; Milano G; Fumoleau P
Cancer Chemother Pharmacol; 2012 Apr; 69(4):871-9. PubMed ID: 22045498
[TBL] [Abstract][Full Text] [Related]
37. Treatment of metastatic breast cancer with vinorelbine and docetaxel.
Savio G; Laudani A; Leonardi V; Pepe A; Scianna C; Gebbia V; Agostara B
Am J Clin Oncol; 2006 Jun; 29(3):276-80. PubMed ID: 16755181
[TBL] [Abstract][Full Text] [Related]
38. Vinorelbine (Navelbine) in the treatment of breast cancer: the European experience.
Fumoleau P; Delozier T; Extra JM; Canobbio L; Delgado FM; Hurteloup P
Semin Oncol; 1995 Apr; 22(2 Suppl 5):22-8; discussion 28-9. PubMed ID: 7740332
[TBL] [Abstract][Full Text] [Related]
39. A phase I study of a daily x3 schedule of intravenous vinorelbine for refractory epithelial ovarian cancer.
Gershenson DM; Burke TW; Morris M; Bast RC; Guaspari A; Hohneker J; Wharton JT
Gynecol Oncol; 1998 Sep; 70(3):404-9. PubMed ID: 9790795
[TBL] [Abstract][Full Text] [Related]
40. Treatment of metastatic breast cancer by navelbine, mitoxantrone and continuous infusion 5-fluorouracil (FMN regimen): results of a pilot study.
Azim HA
J Infus Chemother; 1996; 6(2):102-6. PubMed ID: 8809659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
